Manipal Health Enterprises IPO Allotment Status: Steps to Verify Status & Key Issue Details

03 August 2026
3 min read
whatsapp
facebook
copyToClipboard

The allotment status for the ₹9,275.22 crore Manipal Health Enterprises IPO is likely to be finalised today, August 3, 2026. Investors can check their IPO allotment status on the official websites of the NSE, BSE, and the IPO registrar, KFin Technologies Limited.

Following the completion of the allotment process, the shares are likely to be listed on the NSE and BSE on August 5, 2026.

Procedure to Check Manipal Health Enterprises IPO Allotment Status Online on NSE

  • Visit the NSE’s IPO allotment verification status page here.
  • Select “Equity & SME IPO Bid Details”.
  • In Select Symbol, select “MANIPALHOS”.
  • Enter your PAN No. and Application No.
  • Click “Submit”.

Procedure to Check Manipal Health Enterprises IPO Allotment Status Online on BSE

  • Click here to visit the application status page. 
  • Under Issue Type, select “Equity”.
  • In Issue Name, select “Manipal Health Enterprises Limited”.
  • Enter your “Application No. or PAN No.”
  • Enter the given Captcha correctly.
  • Click “Submit”.

Procedure to Check Manipal Health Enterprises IPO Allotment Status on KFin Technologies Limited (Registrar to the Issue)

  • Visit the KFin Technologies’ IPO allotment status page here.
  • In Select IPO, choose “MANIPAL HEALTH ENTERPRISES LIMITED”.
  • Enter any of the following details.
    • App. No.
    • Demat Account
    • PAN
  • Click “Submit”.

Manipal Health Enterprises IPO - Issue Details

  • Issue Type: Book Built Issue (Fresh Issue + OFS)
  • Total Issue Size: Up to ₹9,275.22 crore
  • Fresh Issue: Up to ₹8,000 crore
  • Offer for Sale (OFS): Up to ₹1,275.22 crore
  • Face Value: ₹2 per equity share
  • Price Band: ₹560 to ₹590 per share
  • Lot Size: 25 shares
  • Minimum Investment Amount (Retail Investor): ₹14,750 (25 shares at the upper price band)
  • Listing: BSE, NSE
  • Book Running Lead Managers: Kotak Mahindra Capital Company Limited, Axis Capital Limited, Goldman Sachs (India) Securities Private Limited, Jefferies India Private Limited, J.P. Morgan India Private Limited, UBS Securities India Private Limited and DBS Bank India Private Limited
  • Registrar: KFin Technologies Limited

Explore other Upcoming IPOs on BSE and NSE.

Manipal Health Enterprises IPO Overall Subscription Status

[July 31, 2026, 7:00 PM]

Category 

Subscription (x)

Qualified Institutional Buyers (QIBs)

8.25x

Non-Institutional Investors (NIIs)

1.02x

Retail Individual Investors (RIIs)

0.93x

Employees

2.19x

Total 

4.92x

Utilisation of IPO Proceeds

The company intends to utilise the net proceeds from the fresh issue towards:

  • Repayment or prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of its material subsidiaries, namely, Manipal Hospitals Private Limited
  •  Acquisition of a minority stake in its stepdown subsidiary, Sahyadri Hospitals Private Limited
  • General corporate purposes.

Explore other Upcoming IPOs on BSE and NSE.

About Manipal Health Enterprises Limited

Manipal Health Enterprises is one of India's prominent multispecialty healthcare providers, with a network of 49 hospitals and 13,037 licensed beds spread across 14 states and union territories as of March 31, 2026. The company is the largest private hospital chain in the country by bed capacity and ranks second in terms of the number of hospitals. In FY26, it catered to around 7.63 million patients and was supported by a network of 11,064 doctors.

The company focuses on delivering tertiary and quaternary healthcare services across specialties such as cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences (CONGO-R). These segments accounted for 64.3% of its gross inpatient revenue during FY26. Manipal Health has expanded its footprint through acquisitions including AMRI Hospitals, Medica Synergie, and the Sahyadri Group. It also aims to increase its capacity by adding nearly 2,426 licensed beds by 2030.

Key Financial Highlights 

Particulars

FY26      

  (in ₹ crore)

FY25      

  (in ₹ crore)

FY24                                         (in ₹ crore)

Revenue from operations

10,335.75

8,242.25

6,171.63

EBITDA

2,795.94

2,247.07

1,776.60

Profit After Tax

916.52

1,081.67

533.20

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here.



Do you like this edition?